RIPK2: a promising target for cancer treatment
As an essential mediator of inflammation and innate immunity, the receptor-interacting serine/threonine-protein kinase-2 (RIPK2) is responsible for transducing signaling downstream of the intracellular peptidoglycan sensors nucleotide oligomerization domain (NOD)-like receptors 1 and 2 (NOD1/2), whi...
Saved in:
Main Authors: | Jieqiong You (Author), Ying Wang (Author), Haifeng Chen (Author), Fang Jin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metal nanoparticles as a promising technology in targeted cancer treatment
by: Jia-Jie Xu, et al.
Published: (2022) -
WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit
by: Xiaomeng Gao, et al.
Published: (2022) -
RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
by: Hajime Honjo, et al.
Published: (2021) -
Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
by: Lingyan Yu, et al.
Published: (2023) -
Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies
by: Jiabin Liu, et al.
Published: (2024)